The 2019 coronavirus disease (COVID-19) infection had newly emerged with predominant respiratory complications. Other extrapulmonary features had been recently described. Here, we describe a COVID-19 patient presenting with multiorgan involvement mimicking systemic lupus erythematosus. He was successfully treated with glucocorticoids and tocilizumab.
All Keywords
【저자키워드】 COVID-19, Acute kidney injury, lupus-like symptoms, multiorgan damages, 【초록키워드】 Tocilizumab, Infection, Respiratory complications, systemic lupus erythematosus, glucocorticoid, 2019 coronavirus disease, Other, Multiorgan, COVID-19 patient, feature, described, treated, predominant, presenting, mimicking, 【제목키워드】 Lupus,
【저자키워드】 COVID-19, Acute kidney injury, lupus-like symptoms, multiorgan damages, 【초록키워드】 Tocilizumab, Infection, Respiratory complications, systemic lupus erythematosus, glucocorticoid, 2019 coronavirus disease, Other, Multiorgan, COVID-19 patient, feature, described, treated, predominant, presenting, mimicking, 【제목키워드】 Lupus,
2019년 코로나바이러스감염증-19(COVID-19) 감염이 호흡기 합병증이 우세하면서 새롭게 등장했습니다. 다른 폐외 특징이 최근에 설명되었습니다. 여기에서 우리는 전신 홍반성 루푸스를 모방한 다기관 침범을 보이는 COVID-19 환자를 설명합니다. 그는 글루코코르티코이드와 토실리주맙으로 성공적으로 치료되었습니다.